• Something wrong with this record ?

Comparison of parturient - controlled remifentanil with epidural bupivacain and sufentanil for labour analgesia: randomised controlled trial

P. Stourac, H. Suchomelova, M. Stodulkova, M. Huser, I. Krikava, P. Janku, O. Haklova, L. Hakl, R. Stoudek, R. Gal, P. Sevcik

. 2014 ; 158 (2) : 227-232. [pub] 20121031

Language English Country Czech Republic

Document type Comparative Study, Journal Article, Randomized Controlled Trial

Persistent link   https://www.medvik.cz/link/bmc15033241

INTRODUCTION: Epidural analgesia (EA) has significant contraindications including coagulation disorders and parturient refusal. One alternative is intravenous self-administered analgesia using the ultra short-acting opioid remifentanil (rPCA). We compared the efficiency and safety of standard epidural analgesia with parturient-controlled intravenous analgesia using remifentanil as well as personal satisfaction. MATERIALS AND METHODS: We enrolled twelve ASA I classified women with singleton pregnancy who delivered vaginally in the period 3/2010-5/2010 and who received rPCA (n=12) in standard analgesic protocol: 20 µg boluses using PCA pump with a lockout interval of 3 min. The control group consisted of 12 pregnant women who received EA (n=12): 0.125% bupivacaine with sufentanil 0.5 µg/mL in top-up boluses every hour until delivery. Data were acquired from standard Acute Pain Service (APS) form and patient medical records (demographic, labour course parameters), Visual Analogue Scale (VAS), Bromage Scale (BS) and adverse effects of analgesia. RESULTS: There were no demographic or labour course parameter differences between groups (P>0.05). The differences in VAS decrease (P=0.056) and parturient satisfaction (P=0.24) during the whole analgesia administration were statistically insignificant. The main limitation of the study was small sample and enrolment of healthy singleton pregnant women only. CONCLUSION: Remifentanil use in obstetric analgesia is a viable alternative to EA, especially in cases of EA contraindications and parturient disapproval.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15033241
003      
CZ-PrNML
005      
20200311164602.0
007      
ta
008      
151016s2014 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2012.073 $2 doi
035    __
$a (PubMed)23128818
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Štourač, Petr $u Department of Anaesthesiology and Intensive Care Medicine, Faculty Hospital Brno, Czech Republic; Department of Pain Control, Faculty Hospital Brno; Faculty of Medicine, Masaryk University, Brno $7 xx0158599
245    10
$a Comparison of parturient - controlled remifentanil with epidural bupivacain and sufentanil for labour analgesia: randomised controlled trial / $c P. Stourac, H. Suchomelova, M. Stodulkova, M. Huser, I. Krikava, P. Janku, O. Haklova, L. Hakl, R. Stoudek, R. Gal, P. Sevcik
520    9_
$a INTRODUCTION: Epidural analgesia (EA) has significant contraindications including coagulation disorders and parturient refusal. One alternative is intravenous self-administered analgesia using the ultra short-acting opioid remifentanil (rPCA). We compared the efficiency and safety of standard epidural analgesia with parturient-controlled intravenous analgesia using remifentanil as well as personal satisfaction. MATERIALS AND METHODS: We enrolled twelve ASA I classified women with singleton pregnancy who delivered vaginally in the period 3/2010-5/2010 and who received rPCA (n=12) in standard analgesic protocol: 20 µg boluses using PCA pump with a lockout interval of 3 min. The control group consisted of 12 pregnant women who received EA (n=12): 0.125% bupivacaine with sufentanil 0.5 µg/mL in top-up boluses every hour until delivery. Data were acquired from standard Acute Pain Service (APS) form and patient medical records (demographic, labour course parameters), Visual Analogue Scale (VAS), Bromage Scale (BS) and adverse effects of analgesia. RESULTS: There were no demographic or labour course parameter differences between groups (P>0.05). The differences in VAS decrease (P=0.056) and parturient satisfaction (P=0.24) during the whole analgesia administration were statistically insignificant. The main limitation of the study was small sample and enrolment of healthy singleton pregnant women only. CONCLUSION: Remifentanil use in obstetric analgesia is a viable alternative to EA, especially in cases of EA contraindications and parturient disapproval.
650    _2
$a dospělí $7 D000328
650    12
$a epidurální analgezie $7 D015360
650    12
$a pacientem kontrolovaná analgezie $7 D016058
650    _2
$a opioidní analgetika $x aplikace a dávkování $7 D000701
650    _2
$a anestetika lokální $x aplikace a dávkování $7 D000779
650    _2
$a bupivakain $x aplikace a dávkování $7 D002045
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a komplikace porodu $x farmakoterapie $7 D007744
650    _2
$a bolest $x farmakoterapie $7 D010146
650    _2
$a měření bolesti $7 D010147
650    _2
$a porod $7 D036801
650    _2
$a piperidiny $x aplikace a dávkování $7 D010880
650    _2
$a těhotenství $7 D011247
650    _2
$a prospektivní studie $7 D011446
650    _2
$a sufentanil $x aplikace a dávkování $7 D017409
650    _2
$a mladý dospělý $7 D055815
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a randomizované kontrolované studie $7 D016449
700    1_
$a Harazim, Hana $7 xx0209334 $u Department of Anaesthesiology and Intensive Care Medicine, Faculty Hospital Brno, Czech Republic; Faculty of Medicine, Masaryk University, Brno
700    1_
$a Stodůlková, M. $7 _AN065019 $u Faculty of Medicine, Masaryk University, Brno
700    1_
$a Huser, Martin $7 xx0077499 $u Department of Obstetrics and Gynecology, Faculty Hospital Brno; Faculty of Medicine, Masaryk University, Brno
700    1_
$a Křikava, Ivo, $d 1976- $7 xx0145465 $u Department of Anaesthesiology and Intensive Care Medicine, Faculty Hospital Brno, Czech Republic; Department of Pain Control, Faculty Hospital Brno; Faculty of Medicine, Masaryk University, Brno
700    1_
$a Janků, Petr, $d 1969- $7 mzk2006343029 $u Department of Obstetrics and Gynecology, Faculty Hospital Brno; Faculty of Medicine, Masaryk University, Brno
700    1_
$a Haklová, Olga $7 xx0063009 $u Department of Pain Control, Faculty Hospital Brno
700    1_
$a Hakl, Lubomír $7 xx0063008 $u Department of Pain Control, Faculty Hospital Brno
700    1_
$a Štoudek, Roman $7 xx0121542 $u Department of Anaesthesiology and Intensive Care Medicine, Faculty Hospital Brno, Czech Republic; Faculty of Medicine, Masaryk University, Brno
700    1_
$a Gál, Roman $7 mzk2004265211 $u Department of Anaesthesiology and Intensive Care Medicine, Faculty Hospital Brno, Czech Republic; Faculty of Medicine, Masaryk University, Brno
700    1_
$a Ševčík, Pavel, $d 1953- $7 mzk2003186005 $u Department of Anaesthesiology and Intensive Care Medicine, Faculty Hospital Brno, Czech Republic; Department of Pain Control, Faculty Hospital Brno; Faculty of Medicine, Masaryk University, Brno
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 158, č. 2 (2014), s. 227-232
856    41
$u http://biomed.papers.upol.cz/ $y domovská stránka časopisu
910    __
$a ABA008 $b A 1502 $c 958 $y 4 $z 0
990    __
$a 20151016 $b ABA008
991    __
$a 20200311165021 $b ABA008
999    __
$a ok $b bmc $g 1095639 $s 916372
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 158 $c 2 $d 227-232 $e 20121031 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK118 $a Pubmed-20151016

Find record

Citation metrics

Archiving options